Relationship between (Na + K)-ATPase activity, lipid peroxidation and fatty acid profile in erythrocytes of hypertensive and normotensive subjects

Molecular and Cellular Biochemistry

Volumn 303, Issue 1-2, 2007, Pages 73-81

  Rodrigo, Ramón ^a   Bächler, Jean P ^a   Araya, Julia ^a   Prat, Hernán ^b   Passalacqua, Walter ^b  

^a UNIVERSITY OF CHILE   (Chile)

^b HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

Author keywords

(Na + K) ATPase; Essential hypertension; Fatty acids; Lipid peroxidation

Indexed keywords

8 ISOPROSTANE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); FATTY ACID; FERRIC ION; GLUTATHIONE; LIPID; MALONALDEHYDE; MEMBRANE PHOSPHOLIPID;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD SAMPLING; CELL STRUCTURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; ENZYME ACTIVITY; ENZYME BINDING; ERYTHROCYTE; ERYTHROCYTE MEMBRANE; ESSENTIAL HYPERTENSION; HUMAN; LIPID COMPOSITION; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PATIENT SELECTION; SYSTOLIC BLOOD PRESSURE; TIME;

ADULT; BLOOD PRESSURE MONITORING, AMBULATORY; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; ERYTHROCYTE MEMBRANE; ERYTHROCYTES; FATTY ACIDS; GLUTATHIONE; HUMANS; HYPERTENSION; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MIDDLE AGED; NA(+)-K(+)-EXCHANGING ATPASE; OXIDATIVE STRESS;

EID: 34547860886     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-007-9457-y     Document Type: Article

References (56)

1. Lassègue B, Griendling K (2004) Reactive oxygen species in hypertension. An update. Am J Hypertens 17:852-860
2. Touyz RM, Schiffrin EL (2004) Reactive oxygen species in vascular biology: Implications in hypertension. Histochem Cell Biol 122:339-352
3. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr et al (2003) Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 289:2560-2572
4. Stidley CA, Hunt WC, Tentori F, Schmidt D, Rohrscheib M, Paine S et al (2006) Changing relationship of blood pressure with mortality over time among hemodialysis patients. J Am Soc Nephrol 17:513-520
5. Chen X, Touyz RM, Bae Park J, Schiffrin EL (2001) Antioxidant effects of vitamins C and E are associated with altered activation of vascular NADPH oxidase and superoxide dismutase in stroke-prone SHR. Hypertension 38:606-611
6. Pedro-Botet J, Covas MI, Martin S, Rubies-Prat J (2000) Decreased endogenous antioxidant enzymatic status in essential hypertension. J Hum Hypertens 14:343-345
7. John S, Schmieder RE (2003) Potential mechanisms of impaired endothelial function in arterial hypertension and hypercholesterolemia. Curr Hypertens Rep 5:199-207
8. Stark G (2005) Functional consequences of oxidative membrane damage. Membr Biol 205:1-16
9. Cazzola R, Rondanelli M, Russo-Volpe S, Ferrari E, Cestaro B (2004) Decreased membrane fluidity and altered susceptibility to peroxidation and lipid composition in overweight and obese female erythrocytes. J Lipid Res 45:1846-1851
10. Elizondo A, Araya J, Rodrigo R, Poniachik J, Signorini C, Sgherri C, Comporti M, Videla LA (2007) Docosahexaenoic acid and docosapentaenoic acid levels in liver and erythrocyte phospholipids from obese non-alcoholic fatty liver disease patients. Obesity 15:24-31
11. Felton CV, Stevenson JC, Godsland IF (2004) Erythrocyte-derived measures of membrane lipid composition in healthy men: Associations with arachidonic acid at low to moderate not high insulin sensitivity. Metabolism 53:571-577
12. Vajreswari A, Rupalatha M, Rao PS (2002) Effect of altered dietary n -6-to- n -3 fatty acid ratio on erythrocyte lipid composition and membrane-bound enzymes. J Nutr Sci Vitaminol (Tokio) 48:365-370
13. Bartoli GM, Palozza P, Luberto C, Franceschelli P, Piccioni E (1995) Dietary fish oil inhibits human erythrocyte Mg,NaK-ATPase. Biochem Biophys Res Commun 213:881-887
14. Rodrigo R, Castillo R (2006) Pathophysiological mechanisms of renal damage by alcohol consumption: Involvement of oxidative stress. In: Yoshida R (ed) Trends in Alcohol Abuse and Alcoholism Research. Nova Publishers
15. 2+ pump in pig coronary artery smooth muscle. Am J Physiol Cell Physiol 284:C294-C301
16. Hamilton BP, Blaustein MP (2006) Molecular mechanisms linking sodium to hypertension: Report of a symposium. J Investig Med 54:86-94
17. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr et al (2003). Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 289:2560-2572
18. Myers MG, Tobe SW, McKay DW, Bolli P (2005) New algorithm for the diagnosis of hypertension. Am J Hypertens 18:1369-1374
19. O'Brien E, Mee F, Atkins N, O'Malley K (1991) Short report: Accuracy of the Spacelabs 90207 determined by to the British Hypertension Society Protocol. J Hypertens 9:573-574
20. Groppelli A, Omboni S, Parati G, Mancia G (1992) Evaluation of noninvasive blood pressure monitoring devices Spacelabs 90202 and 90207 versus resting and ambulatory 24-h intra-arterial blood pressure. Hypertension 20:227-232
21. Sun M, Tien J, Jones R, Ward R (1996) A new approach to reproducibility assessment: Clinical evaluation of SpaceLabs Medical oscillometric blood pressure monitor. Biomed Instrum Technol 30:439-448
22. Benzie IF, Strain JJ (1996) The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": The FRAP assay. Anal Biochem 239:70-76
23. Hissin PJ, Hilf R (1976) A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal Biochem 74:214-226
24. Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351-358
25. Pradelles P, Grassi J, Maclouf J (1985) Enzyme immunoassays of eicosanoids using AchE as label: An alternative to radioimmunoassay. Anal Chem 57:1170-1173
26. Katz AI, Epstein FH (1967) The role of sodium-potassium-activated adenosine triphosphatase in the reabsorption of sodium by the kidney. J Clin Invest 46:1999-2011
27. Taussky HH, Shorr E (1953) A microcolorimetric method for the determination of inorganic phosphorus. J Biol Chem 202:675-685
28. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275
29. Huertas JR, Palomino N, Ochoa JJ, Quiles JL, Ramirez-Tortosa MC, Battino M, Robles R, Mataix J (1998) Lipid peroxidation and antioxidants in erythrocyte membranes of full-term and preterm newborns. Biofactors 8:133-137
30. Bligh EG, Dyer WJ (1959) A rapid method of total lipid extraction. Can J Biochem Physiol 37:911-917
31. Araya J, Rodrigo R, Orellana M, Rivera G (2001) Red wine raises HDL and preserves long-chain polyunsaturated fatty acids in rat kidney and erythrocytes. Br J Nutr 86:189-195
32. Redon J, Oliva MR, Tormos C, Giner V, Chaves J, Iradi A, Saez GT (2003) Antioxidant activities and oxidative stress byproducts in human hypertension. Hypertension 41:1096-1101
33. Kashyap MK, Yadav V, Sherawat BS, Jain S, Kumari S, Khullar M et al (2005) Different antioxidants status, total antioxidant power and free radicals in essential hypertension. Mol Cell Biochem 277:89-99
34. Hozawa A, Ebihara S, Ohmori K, Kuriyama S, Ugajin T, Yayoi Koizumi Y et al (2004) Increased plasma 8-isoprostane levels in hypertensive subjects: The Tsurugaya project. Hypertens Res 27:557-561
35. Gibson RA, Neumann MA, Burnard SL, Rinaldi JA, Patten GS, McMurchie EJ (1992) The effect of dietary supplementation with eicosapentaenoic acid on the phospholipid and fatty acid composition of erythrocytes of marmoset. Lipids 27:169-176
36. Knapp HR, Hullin F, Salem N Jr (1994) Asymmetric incorporation of dietary n-3 fatty acids into membrane aminophospholipids of human erythrocytes. J Lipid Res 35:1283-1291
37. Alexander-North LS, North JA, Kiminyo KP, Buettner GR, Spector AA (1994) Polyunsaturated fatty acids increase lipid radical formation induced by oxidant stress in endothelial cells. J Lipid Res 35:1773-1785
38. Van Ginkel G, Sevanian A (1994) Lipid peroxidation-induced membrane structural alterations. Methods Enzymol 233:273-288
39. 2+)-ATPase by nonheme iron. Biochim Biophys Acta 1062:35-38
40. Fukuda K, Davies SS, Nakajima T, Ong BH et al (2005) Oxidative mediated lipid peroxidation recapitulates proarrhythmic effects on cardiac sodium channels. Circ Res 97:1262-1269
41. Kocak-Toker N, Giris M, Tulubas F, Uysal M, Aykac-Toker G (2005) Peroxynitrite induced decrease in Na+, K+-ATPase activity is restored by taurine. World J Gastroenterol 11:3554-3557
42. Norman RI, Achall N. (1993) Cell membrane microviscosity and Ca(2+)-Mg(2+)-ATPase activity do not contribute to hypertension in the spontaneously hypertensive rat model. Clin Sci (Lond) 85:585-591
43. Liu Y, Longmore RB (1997) Dietary sandalwood seed oil modifies fatty acid composition of mouse adipose tissue, brain, and liver. Lipids 32:965-969
44. Begin ME (1990) Fatty acids, lipid peroxidation and diseases. Proc Nutr Soc 49:261-267
45. De Lorgeril M, Salen P (2003) Dietary prevention of coronary heart disease: Focus on omega-6/omega-3 essential fatty acid balance. World Rev Nutr Diet 92:57-73
46. Harris WS (2006) The omega-6/omega-3 ratio and cardiovascular disease risk: Uses and abuses. Curr Atheroscler Rep 8:453-459
47. Wijendran V, Hayes KC (2004) Dietary n-6 and n-3 fatty acid balance and cardiovascular health. Annu Rev Nutr 24:597-615
48. Iwamoto T, Kita S (2006) Topics on the Na+/Ca2+ exchanger: Role of vascular NCX1 in salt-dependent hypertension. J Pharmacol Sci 102:32-36
49. Hallaq HA, Haupert GT Jr (1989) Positive inotropic effects of the endogenous Na+/K(+)-transporting ATPase inhibitor from the hypothalamus. Proc Natl Acad Sci USA 86:10080-10084
50. Shaikh IM, Lau BW, Siegfried BA, Valdes R Jr (1991) Isolation of digoxin-like immunoreactive factors from mammalian adrenal cortex. J Biol Chem 266:13672-13678
51. Manunta P, Stella P, Rivera R et al (1999) Left ventricular mass, stroke volume, and ouabain-like factor in essential hypertension. Hypertension. 34:450-456
52. Zhang W, Huang BS, Leenen FH (1999) Brain renin-angiotensin system and sympathetic hyperactivity in rats after myocardial infarction. Am J Physiol 276:H1608-H1615
53. Dostanic-Larson I, Van Huysse JW, Lorenz JN, Lingrel JB (2005) The highly conserved cardiac glycoside binding site of Na,K-ATPase plays a role in blood pressure regulation. Proc Natl Acad Sci USA 102:15845-15850
54. Dostanic I, Paul RJ, Lorenz JN, Theriault S, Van Huysse JW, Lingrel JB (2005) The alpha2-isoform of Na-K-ATPase mediates ouabain-induced hypertension in mice and increased vascular contractility in vitro. Am J Physiol Heart Circ Physiol 288:H477-H485
55. Kaplan JH (2005) The sodium pump and hypertension: A physiological role for the cardiac glycoside binding site of the Na,K-ATPase. Proc Natl Acad Sci USA 102:15723-15724
56. Bova S, Blaustein MP, Ludens JH, Harris DW, DuCharme DW, Hamlyn JM (1991) Effects of an endogenous ouabain-like compound on heart and aorta. Hypertension 17:944-950